Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes

    ... trioxide (ATO). Twenty-two MDS patients receiving supportive care were used as controls. The remission was achieved in 4 patients ...

    Research Article last updated 06/15/2012 - 2:20pm.

  2. Treatment of myelodysplastic syndromes in elderly patients.

    ... the longest possible time. To achieve these objectives, supportive care is essential. Likewise, immunomodulatory drugs, such as ...

    Research Article last updated 02/10/2012 - 9:43am.

  3. Optimizing management of myelodysplastic syndromes post-allogeneic transplantation

    ... syndromes . Improvements in donor selection, supportive care and the introduction of reduced-intensity conditioning have led to a ...

    Research Article last updated 12/05/2011 - 10:23am.

  4. Management of aplastic anemia: the role of systematic reviews and meta-analyses.

    ... roles of alloHCT, IST, hematopoietic growth factors and supportive care . Bone Marrow ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Infections in patients with aplastic anemia.

    ... from neutropenia is directly related to survival, and supportive care plays a large role in protection while the patient is in a ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia.

    ... effective novel conditioning regimens, improvement of supportive care and expansion of the donor registry. Decision making regarding the ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. Azacytidine for the treatment of myelodysplastic syndromes in the elderly.

    ... MDS treated with 5-AZA as well as the management and supportive care measures for adverse events. As expected, based on available clinical ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. The search for better prognostic models in myelodysplastic syndromes.

    ... for discerning the best therapy, which can vary from supportive care to allogeneic stem cell transplantation. The most widely used ...

    Research Article last updated 10/11/2011 - 5:58pm.

  9. An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes.

    ... of treatment includes cytoxic chemotherapy and supportive care . Over the last decade, promising results from studies focusing on ...

    Research Article last updated 10/11/2011 - 5:58pm.

  10. Epigenetic therapy in myelodysplastic syndromes.

    ... available: most patients are, indeed, still managed by supportive care measures, with just a minority of them being eligible for allogeneic ...

    Research Article last updated 10/11/2011 - 5:58pm.